Overview

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
To test whether celecoxib can be used to prevent colon polyp formation in children with familial adenomatous polyposis (FAP).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Celecoxib